rivfloza

Generic: nedosiran

Labeler: novo nordisk
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name rivfloza
Generic Name nedosiran
Labeler novo nordisk
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

nedosiran sodium 128 mg/.8mL

Manufacturer
Novo Nordisk

Identifiers & Regulatory

Product NDC 0169-5307
Product ID 0169-5307_758d66fb-0447-4f26-905f-595b182aebdc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA215842
Listing Expiration 2026-12-31
Marketing Start 2024-02-19

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01695307
Hyphenated Format 0169-5307

Supplemental Identifiers

RxCUI
2675303 2675309 2675312 2675315 2675317 2675318
UNII
EGR9KYM536

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rivfloza (source: ndc)
Generic Name nedosiran (source: ndc)
Application Number NDA215842 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 128 mg/.8mL
source: ndc
Packaging
  • 1 SYRINGE in 1 CARTON (0169-5307-08) / .8 mL in 1 SYRINGE
source: ndc

Packages (1)

0169-5307-08 1 SYRINGE in 1 CARTON (0169-5307-08) / .8 mL in 1 SYRINGE

Ingredients (1)

nedosiran sodium (128 mg/.8mL)

Linked Drug Pages (1)

RIVFLOZA ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "758d66fb-0447-4f26-905f-595b182aebdc", "openfda": {"unii": ["EGR9KYM536"], "rxcui": ["2675303", "2675309", "2675312", "2675315", "2675317", "2675318"], "spl_set_id": ["ace9d4bc-4d20-4beb-9e9d-888690424833"], "manufacturer_name": ["Novo Nordisk"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (0169-5307-08)  / .8 mL in 1 SYRINGE", "package_ndc": "0169-5307-08", "marketing_start_date": "20240219"}], "brand_name": "RIVFLOZA", "product_id": "0169-5307_758d66fb-0447-4f26-905f-595b182aebdc", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "0169-5307", "generic_name": "nedosiran", "labeler_name": "Novo Nordisk", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RIVFLOZA", "active_ingredients": [{"name": "NEDOSIRAN SODIUM", "strength": "128 mg/.8mL"}], "application_number": "NDA215842", "marketing_category": "NDA", "marketing_start_date": "20240219", "listing_expiration_date": "20261231"}